EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Role of Endothelin‐1, Kidney Function and Diabetes in Patients With Coronary Artery Disease Underwent Percutaneous Coronary Intervention

Zixiang Ye, Enmin Xie, Yuan Du, Wenjia Zhang, Kefei Dou iD

Journal of Diabetes · 2025

DOI: 10.1111/1753-0407.70127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes, 2025. Verfasst von Zixiang Ye und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical C…. Hauptthemen laut MEDLINE: Endothelin-1, Percutaneous Coronary Intervention, Coronary Artery Disease, Diabetes Mellitus. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National High Level Hospital Clinical Research Funding, the CAMS Innovation Fund for Medical Sciences (CIFMS), the Noncommunicable Chronic Diseases-National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to explore the association between plasma big endothelin‐1 (ET‐1) and major adverse cardiovascular events (MACE) in CAD patients who underwent PCI with a focus on the influence of kidney function and diabetes status in secondary prevention.

Methods

A prospective cohort of CAD patients underwent PCI and patients with impaired kidney function and diabetes were initially screened and categorized separately, subdivided based on ET‐1 levels. The primary outcome was MACE, including all‐cause mortality, nonfatal myocardial infarction, unplanned revascularization, and stroke. Statistical analyses included Cox regression, competing risks analysis (competing for non‐cardiovascular death), and restricted cubic spline to assess the relationships between ET‐1 and MACE.

Results

This study included 1344 CAD patients with impaired kidney function and 10,577 CAD patients with DM. During a median follow‐up of 3 years, 20% of renal dysfunction patients and 12.9% of DM patients experienced MACE. In CAD patients with renal dysfunction, elevated ET‐1 levels were associated with increased MACE risk (adjusted HR 1.333, 95% CI 1.169–1.519, p < 0.001), with those in the highest group and DM showing a 2.134‐fold (95% CI, 1.334–3.413, p < 0.001) increased MACE risk. In CAD patients with DM, patients with eGFR ≤ 60 mL/min/1.73 m 2 and elevated ET‐1 levels had a 2.297‐fold (95% CI 1.822–2.895) increased risk of MACE.

Conclusion

ET‐1 offered important prognostic value for CAD patients who underwent PCI, with especially bad prognoses observed in those with elevated ET‐1 levels, renal dysfunction, and DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endothelin-1Percutaneous Coronary InterventionCoronary Artery DiseaseDiabetes MellitusKidneyHumansMaleFemaleMiddle AgedAgedProspective StudiesRisk FactorsGlomerular Filtration RateFollow-Up StudiesBiomarkersPrognosis

Stichwörter der Autor:innen

Endothelin‐1coronary artery diseasediabetes mellitusimpaired kidney functionmajor adverse cardiovascular events

Substanzen

Endothelin-1Biomarkers

Autor:innen und Institutionen

  • Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • State Key Laboratory of Cardiovascular Disease, Beijing, China.
  • Cardiometabolic Medicine Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • National Clinical Research Center for Cardiovascular Diseases, Beijing, China.

ORCID-Profile: Kefei Dou

Förderung

  • the National High Level Hospital Clinical Research Funding
  • the CAMS Innovation Fund for Medical Sciences (CIFMS)
  • the Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • the Fundamental Research Funds for the Central Universities
  • Beijing Natural Science Foundation
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Ye, Z., Xie, E., Du, Y., Zhang, W., & Dou, K. (2025). The Role of Endothelin‐1, Kidney Function and Diabetes in Patients With Coronary Artery Disease Underwent Percutaneous Coronary Intervention. Journal of Diabetes. https://doi.org/10.1111/1753-0407.70127

Vancouver

Ye Z, Xie E, Du Y, Zhang W, Dou K. The Role of Endothelin‐1, Kidney Function and Diabetes in Patients With Coronary Artery Disease Underwent Percutaneous Coronary Intervention. Journal of Diabetes. 2025. doi:10.1111/1753-0407.70127

BibTeX
@article{Ye2025,
  author = {Ye, Zixiang and Xie, Enmin and Du, Yuan and Zhang, Wenjia and Dou, Kefei},
  title = {The Role of Endothelin‐1, Kidney Function and Diabetes in Patients With Coronary Artery Disease Underwent Percutaneous Coronary Intervention},
  journal = {Journal of Diabetes},
  year = {2025},
  doi = {10.1111/1753-0407.70127}
}
Kostenlos starten →